SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 325 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $92,750,877 | +348.4% | 765,145 | +323.7% | 0.05% | +318.2% |
| Q2 2023 | $20,683,114 | +21954.5% | 180,607 | -73.5% | 0.01% | -79.6% |
| Q1 2023 | $93,782 | +80.0% | 680,424 | +69.3% | 0.05% | +86.2% |
| Q4 2022 | $52,090 | -99.9% | 401,991 | -43.6% | 0.03% | -38.3% |
| Q3 2022 | $78,786,000 | +222.7% | 712,738 | +118.9% | 0.05% | +213.3% |
| Q2 2022 | $24,412,000 | +82.3% | 325,666 | +90.0% | 0.02% | +114.3% |
| Q1 2022 | $13,391,000 | -56.2% | 171,415 | -49.5% | 0.01% | -56.2% |
| Q4 2021 | $30,583,000 | +186.0% | 339,619 | +193.7% | 0.02% | +166.7% |
| Q3 2021 | $10,695,000 | +75.1% | 115,652 | +47.2% | 0.01% | +50.0% |
| Q2 2021 | $6,109,000 | -77.9% | 78,590 | -78.8% | 0.00% | -80.0% |
| Q1 2021 | $27,590,000 | -7.1% | 370,183 | +112.5% | 0.02% | -4.8% |
| Q4 2020 | $29,697,000 | +145.2% | 174,189 | +102.0% | 0.02% | +40.0% |
| Q3 2020 | $12,112,000 | -39.5% | 86,252 | -30.9% | 0.02% | -44.4% |
| Q2 2020 | $20,005,000 | +27.5% | 124,766 | -22.2% | 0.03% | -22.9% |
| Q1 2020 | $15,695,000 | -22.8% | 160,444 | +1.8% | 0.04% | +40.0% |
| Q4 2019 | $20,340,000 | +342.5% | 157,627 | +158.2% | 0.02% | +257.1% |
| Q3 2019 | $4,597,000 | -62.4% | 61,041 | -24.2% | 0.01% | -61.1% |
| Q2 2019 | $12,239,000 | -59.0% | 80,545 | -67.9% | 0.02% | -59.1% |
| Q1 2019 | $29,864,000 | -31.8% | 250,554 | -37.6% | 0.04% | -36.2% |
| Q4 2018 | $43,806,000 | -56.6% | 401,405 | -35.7% | 0.07% | -44.4% |
| Q3 2018 | $100,902,000 | -11.1% | 624,740 | -27.2% | 0.12% | -16.2% |
| Q2 2018 | $113,464,000 | +239.7% | 858,407 | +90.4% | 0.15% | +228.9% |
| Q1 2018 | $33,401,000 | -25.1% | 450,819 | -43.8% | 0.04% | -27.4% |
| Q4 2017 | $44,622,000 | -18.9% | 801,971 | -33.8% | 0.06% | -26.2% |
| Q3 2017 | $54,989,000 | +19.9% | 1,212,268 | -10.9% | 0.08% | +2.4% |
| Q2 2017 | $45,863,000 | +1052.3% | 1,360,526 | +911.8% | 0.08% | +1071.4% |
| Q1 2017 | $3,980,000 | -67.1% | 134,461 | -69.5% | 0.01% | -73.1% |
| Q4 2016 | $12,110,000 | -90.7% | 441,497 | -79.3% | 0.03% | -88.1% |
| Q3 2016 | $130,840,000 | +1150.0% | 2,130,604 | +288.2% | 0.22% | +812.5% |
| Q2 2016 | $10,467,000 | +306.8% | 548,850 | +316.3% | 0.02% | +300.0% |
| Q1 2016 | $2,573,000 | -94.7% | 131,830 | -89.6% | 0.01% | -94.2% |
| Q4 2015 | $48,846,000 | +178.9% | 1,266,095 | +132.1% | 0.10% | +202.9% |
| Q3 2015 | $17,515,000 | +539.5% | 545,471 | +506.1% | 0.03% | +580.0% |
| Q2 2015 | $2,739,000 | +58.7% | 90,000 | -30.8% | 0.01% | +66.7% |
| Q1 2015 | $1,726,000 | -9.9% | 130,000 | -1.7% | 0.00% | -40.0% |
| Q4 2014 | $1,915,000 | +3.6% | 132,305 | +51.0% | 0.01% | 0.0% |
| Q3 2014 | $1,848,000 | -71.4% | 87,604 | -59.6% | 0.01% | -72.2% |
| Q2 2014 | $6,465,000 | +1203.4% | 217,017 | +950.4% | 0.02% | +1700.0% |
| Q1 2014 | $496,000 | -69.9% | 20,660 | -74.5% | 0.00% | -80.0% |
| Q4 2013 | $1,648,000 | -87.8% | 80,900 | -71.8% | 0.01% | -88.6% |
| Q3 2013 | $13,552,000 | +658.4% | 286,930 | +510.5% | 0.04% | +780.0% |
| Q2 2013 | $1,787,000 | – | 47,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 1,010,330 | $122,472,203 | 13.56% |
| Finepoint Capital LP | 145,357 | $17,620,176 | 8.78% |
| Avoro Capital Advisors LLC | 4,025,000 | $487,910,500 | 7.61% |
| Saturn V Capital Management LP | 118,401 | $14,352,569 | 6.01% |
| Ghost Tree Capital, LLC | 150,000 | $18,183,000 | 5.98% |
| Ikarian Capital, LLC | 3,673 | $44,524,106 | 5.36% |
| ACUTA CAPITAL PARTNERS, LLC | 550 | $7,580,650 | 5.08% |
| Eagle Health Investments LP | 174,212 | $21,117,979 | 4.65% |
| Boxer Capital, LLC | 600,000 | $72,732,000 | 3.87% |
| GREAT POINT PARTNERS LLC | 165,200 | $20,025,544 | 3.65% |